Table 2.
Comparison of tele-oncology versus in-person visit determinations of growth and development of new risk factors
| Tele-oncology visit, % | In-person visit, % | |
|---|---|---|
| Basal growth | ||
| No growth | 93 (94) | 94 (95) |
| Equivocal | 3 (3) | 2 (2) |
| Definite | 3 (3) | 3 (3) |
| Axial growth | ||
| No growth | 92 (93) | 93 (94) |
| Equivocal | 4 (4) | 4 (4) |
| Definite | 3 (3) | 2 (2) |
| Any growth | ||
| No growth | 88 (89) | 89 (90) |
| Growth* | 11 (11) | 10 (10) |
| New OP | 0 (0) | 0 (0) |
| New SRF | 0 (0) | 0 (0) |
*
Growth includes axial and/or basal, definite or equivocal growth. OP, orange pigment; SRF, subretinal fluid.